Menu
GeneBe

TTC14

tetratricopeptide repeat domain 14, the group of Tetratricopeptide repeat domain containing

Basic information

Region (hg38): 3:180602162-180617828

Links

ENSG00000163728NCBI:151613HGNC:24697Uniprot:Q96N46AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the TTC14 gene.

  • Primary ciliary dyskinesia (104 variants)
  • Primary ciliary dyskinesia 14 (56 variants)
  • Inborn genetic diseases (36 variants)
  • not provided (16 variants)
  • not specified (13 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the TTC14 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
28
clinvar
2
clinvar
30
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
13
clinvar
3
clinvar
66
clinvar
38
clinvar
11
clinvar
131
Total 13 3 94 40 11

Highest pathogenic variant AF is 0.0000329

Variants in TTC14

This is a list of pathogenic ClinVar variants found in the TTC14 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
3-180602297-C-G not specified Uncertain significance (Nov 30, 2021)2348279
3-180602344-A-G not specified Uncertain significance (Oct 12, 2021)2344122
3-180602910-A-G not specified Uncertain significance (Jun 13, 2023)2559944
3-180602935-C-T not specified Uncertain significance (Apr 07, 2022)2205018
3-180602983-C-T not specified Uncertain significance (Sep 14, 2022)2370433
3-180602997-A-C not specified Uncertain significance (Dec 20, 2023)3184083
3-180603009-A-G not specified Uncertain significance (Oct 26, 2021)2226235
3-180603109-A-AT TTC14-related disorder Benign (Sep 23, 2019)3059709
3-180603130-A-G not specified Uncertain significance (Nov 10, 2022)2343209
3-180603174-A-G not specified Uncertain significance (Dec 08, 2023)3184084
3-180603199-G-A not specified Uncertain significance (Dec 19, 2022)2337016
3-180603243-A-G not specified Uncertain significance (Nov 10, 2022)2323226
3-180603295-T-A not specified Uncertain significance (Dec 17, 2023)3184085
3-180603306-G-A not specified Uncertain significance (Dec 06, 2023)3184086
3-180604857-G-A not specified Uncertain significance (May 03, 2023)2522669
3-180604857-G-C not specified Uncertain significance (Oct 25, 2022)2319056
3-180604940-G-C not specified Uncertain significance (Mar 03, 2022)2396852
3-180604953-A-G not specified Likely benign (Aug 09, 2021)2376324
3-180605796-T-C TTC14-related disorder Benign (Jul 12, 2019)3050662
3-180606262-C-T TTC14-related disorder Likely benign (Nov 21, 2019)3048566
3-180606487-G-A TTC14-related disorder Benign (Sep 18, 2019)3038263
3-180606574-C-T TTC14-related disorder Likely benign (Aug 12, 2019)3035715
3-180606587-G-A not specified Uncertain significance (Jan 29, 2024)3184078
3-180608750-A-C not specified Uncertain significance (Apr 14, 2022)2254213
3-180608773-G-A not specified Uncertain significance (May 25, 2022)2290954

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
TTC14protein_codingprotein_codingENST00000296015 1215699
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.18e-90.98412562801201257480.000477
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.2993713880.9570.00001895045
Missense in Polyphen81102.620.789331271
Synonymous-0.1421391371.020.000006571388
Loss of Function2.332034.80.5750.00000161518

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.001070.00105
Ashkenazi Jewish0.000.00
East Asian0.0002220.000217
Finnish0.0008780.000878
European (Non-Finnish)0.0005440.000536
Middle Eastern0.0002220.000217
South Asian0.0003040.000294
Other0.0003270.000326

dbNSFP

Source: dbNSFP

Pathway
Ectoderm Differentiation (Consensus)

Recessive Scores

pRec
0.104

Intolerance Scores

loftool
0.526
rvis_EVS
-0.02
rvis_percentile_EVS
52.25

Haploinsufficiency Scores

pHI
0.102
hipred
Y
hipred_score
0.715
ghis
0.604

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.936

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ttc14
Phenotype

Gene ontology

Biological process
Cellular component
Molecular function
nucleic acid binding